Instead, the magnitudes of the increase in the proportion of CD8+ T cells and the decrease in the proportion of CD4+ T cells after CRT termination were significantly associated with residual lymph node metastasis (Fig. 4c). Here, CD8A is linked to metastatic malignant neoplasm in the lymph nodes.